Ocular Oncology Program Overview

Mayo Clinic's Ocular Oncology Program offers a full range of eye cancer treatment options. There are many different types of eye cancer that can affect the surface of the eye, structures inside the eye or tissues surrounding the eye. At Mayo Clinic, you will receive comprehensive evaluation and treatment with a unique multidisciplinary team specifically trained to treat your type of cancer.

Some types of eye cancer treated at Mayo Clinic include:

  • Conjunctival melanoma
  • Ocular surface squamous neoplasia (OSSN)
  • Retinoblastoma
  • Uveal melanoma
  • Vitreoretinal lymphoma

We also treat and monitor benign eye tumors to help preserve eyesight and detect cancer development at its earliest stage, when it's most treatable. The oculoplastic surgery team treats cancer of the eyelids, sinuses and eye socket in collaboration with dermatologists and otolaryngologists.

Your treatment team

To provide the exact care you need, your multidisciplinary eye cancer team may include an ocular oncologist working with:

  • Retina specialists
  • Pediatric ophthalmologists
  • Cornea specialists
  • Oculoplastic surgeons
  • Adult and pediatric medical oncologists
  • Radiation oncologists
  • Medical physicists
  • Neuroradiologists
  • Interventional radiologists
  • Ophthalmic geneticists
  • Pathologists
  • Social workers
  • Counselors
  • Nurses
  • Ophthalmic technicians
  • Photographers
  • Ultrasonographers

Your unique team is tailored specifically to your needs to provide a comprehensive approach to eye cancer care.

The Mayo Clinic eye cancer team is committed to ongoing research to improve treatment options, reduce treatment side effects and preserve vision when possible.

Procedures

Available treatments for intraocular tumors include :

  • Brain stereotactic radiosurgery
  • Cryotherapy
  • Intra-arterial chemotherapy
  • Intravenous chemotherapy
  • Intravitreal chemotherapy
  • Photodynamic therapy
  • Plaque radiotherapy
  • Proton therapy
  • Transpupillary thermotherapy
  • Tumor resection
Oct. 11, 2022